Liabilities / Assets
75th percentile
Higher debt load relative to assets than 75% of similar nonprofits.
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
0.23x
Liabilities / Revenue
83rd percentile
Higher debt load relative to revenue than 83% of similar nonprofits.
Net Margin
79th percentile
Higher net margin than 79% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
75th percentile
Faster asset growth than 75% of similar nonprofits.
Revenue Growth
85th percentile
Faster revenue growth than 85% of similar nonprofits.
Balance Sheet
Assets
Up$768,430
Up $118,305 (+18%) from 2018
Net Assets
Up$591,405
Up $133,954 (+29%) from 2018
Liabilities
Down$177,025
Down $15,649 (-8.1%) from 2018
Revenue And Expenses
Revenue
Up$492,468
Up $156,895 (+47%) from 2018
Expenses
Up$379,380
Up $87,777 (+30%) from 2018
Net Income
Up$113,088
Up $69,118 (+157%) from 2018
Historical Trend
Filing Detail Status
This 2019 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Jump To
Filing Snapshot
- Filing Period
- Jan 1, 2019 to Dec 31, 2019
Mission and Program Overview
Mission
Oligo nation advocates and fundraises to support medical research into oligodendroglioma brain cancer. We engage with others in the oligodendroglioma community to raise money and we work with researchers and research institutions to identify opportunities to fund translational research that can potentially lead to new treatments in the next 5 years.
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2019 • Form 990Summary only. Only limited summary data is available for this year.
- Assets
- $768,430
- Liabilities
- $177,025
- Net assets
- $591,405
- Revenue
- $492,468
- Expenses
- $379,380
- Net income
- $113,088